226 related articles for article (PubMed ID: 18157070)
1. Effect of highly active antiretroviral therapy on incidence of early syphilis in HIV-infected patients.
Park WB; Jang HC; Kim SH; Kim HB; Kim NJ; Oh MD; Choe KW
Sex Transm Dis; 2008 Mar; 35(3):304-6. PubMed ID: 18157070
[TBL] [Abstract][Full Text] [Related]
2. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC
Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981
[TBL] [Abstract][Full Text] [Related]
3. Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis.
Cicconi P; Cozzi-lepri A; Orlando G; Matteelli A; Girardi E; Degli Esposti A; Moioli C; Rizzardini G; Chiodera A; Ballardini G; Tincati C; d'Arminio Monforte A;
Infection; 2008 Feb; 36(1):46-53. PubMed ID: 18231722
[TBL] [Abstract][Full Text] [Related]
4. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
5. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
[TBL] [Abstract][Full Text] [Related]
6. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
7. Syphilis epidemiology and clinical outcomes in HIV-infected and HIV-uninfected patients in Kaiser Permanente Northern California.
Horberg MA; Ranatunga DK; Quesenberry CP; Klein DB; Silverberg MJ
Sex Transm Dis; 2010 Jan; 37(1):53-8. PubMed ID: 19734820
[TBL] [Abstract][Full Text] [Related]
8. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
[TBL] [Abstract][Full Text] [Related]
9. Primary varicella and herpes zoster among HIV-infected children from 1989 to 2006.
Wood SM; Shah SS; Steenhoff AP; Rutstein RM
Pediatrics; 2008 Jan; 121(1):e150-6. PubMed ID: 18086820
[TBL] [Abstract][Full Text] [Related]
10. Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
Roux P; Carrieri MP; Cohen J; Ravaux I; Poizot-Martin I; Dellamonica P; Spire B
Clin Infect Dis; 2009 Nov; 49(9):1433-40. PubMed ID: 19807275
[TBL] [Abstract][Full Text] [Related]
11. Changing sociodemographic and clinical characteristics of tuberculosis among HIV-infected patients, New York City, 1992-2005.
Harris TG; Li J; Hanna DB; Munsiff SS
Clin Infect Dis; 2010 Jun; 50(11):1524-31. PubMed ID: 20415570
[TBL] [Abstract][Full Text] [Related]
12. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors.
Corral I; Quereda C; Moreno A; Pérez-Elías MJ; Dronda F; Casado JL; Muriel A; Masjuán J; Alonso-de-Leciñana M; Moreno S
Cerebrovasc Dis; 2009; 27(6):559-63. PubMed ID: 19390181
[TBL] [Abstract][Full Text] [Related]
13. High frequency of highly active antiretroviral therapy modifications in patients with acute or early human immunodeficiency virus infection.
Sabundayo BP; McArthur JH; Langan SJ; Gallant JE; Margolick JB
Pharmacotherapy; 2006 May; 26(5):674-81. PubMed ID: 16637796
[TBL] [Abstract][Full Text] [Related]
14. Post-HAART tuberculosis in adults and adolescents with HIV in India: incidence, clinical and immunological profile.
Rajasekaran S; Raja K; Jeyaseelan L; Vijilat S; Priya K; Mohan K; Parvez A; Mahilmaran A; Chandrasekar C
Indian J Tuberc; 2009 Apr; 56(2):69-76. PubMed ID: 19810588
[TBL] [Abstract][Full Text] [Related]
15. Pneumococcal pneumonia in HIV-infected patients by antiretroviral therapy periods.
Saindou M; Chidiac C; Miailhes P; Voirin N; Baratin D; Amiri M; Livrozet JM; Touraine JL; Trepo C; Peyramond D; Vanhems P
HIV Med; 2008 Apr; 9(4):203-7. PubMed ID: 18298578
[TBL] [Abstract][Full Text] [Related]
16. A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto, South Africa.
Bolhaar MG; Karstaedt AS
Clin Infect Dis; 2007 Jul; 45(2):254-60. PubMed ID: 17578788
[TBL] [Abstract][Full Text] [Related]
17. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan.
Fang CT; Hsu HM; Twu SJ; Chen MY; Chang YY; Hwang JS; Wang JD; Chuang CY;
J Infect Dis; 2004 Sep; 190(5):879-85. PubMed ID: 15295691
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels of intact and cleaved urokinase receptor decrease in HIV-1-infected patients initiating highly active antiretroviral therapy.
Ostrowski SR; Katzenstein TL; Pedersen M; Høyer-Hansen G; Gerstoft J; Pedersen BK; Ullum H
Scand J Immunol; 2006 Jun; 63(6):478-86. PubMed ID: 16764702
[TBL] [Abstract][Full Text] [Related]
19. Factors determining serologic response to treatment in patients with syphilis.
González-López JJ; Guerrero ML; Luján R; Tostado SF; de Górgolas M; Requena L
Clin Infect Dis; 2009 Nov; 49(10):1505-11. PubMed ID: 19842977
[TBL] [Abstract][Full Text] [Related]
20. Effect of early initiation of highly active antiretroviral therapy on CD4 cell count and HIV-RNA viral load trends within 24 months of the onset of acute retroviral syndrome.
Voirin N; Routy JP; Smith D; Baratin D; Trépo C; Cotte L; Touraine JL; Livrozet JM; Cooper DA; Ritter J; André P; Vanhems P
HIV Med; 2008 Jul; 9(6):440-4. PubMed ID: 18705761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
